Newsletter | August 19, 2026

08.19.26 -- AI, Open Source, And The Future Of Biostatistics

SPONSOR

Join the August 20, 2026 Life Science Leader Live event at 11 AM Eastern by registering for free today. Life Science Leader Chief Editor Ben Comer and experienced panelists will discuss key changes at the FDA, how companies can get the most out of agency interactions, and strategies to lower risks and avoid regulatory surprises. Reserve your spot today.

FEATURED ARTICLE

July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing

Mathini Ilancheran explores how delayed U.S. tariffs on generic drug imports may reshape supply chains, sourcing strategies, costs, and clinical trial planning across the pharmaceutical industry today.

INDUSTRY INSIGHTS

From Legislation To Action: Emerging Health Policy Priorities

See late‑2025 policy actions, including international pricing agreements, new payment models, and global regulatory changes, while previewing key themes expected to shape 2026 health policy.

AI, Open Source, And The Future Of Biostatistics

Embrace the transformation by integrating AI, open-source innovation, and evolving data standards to shape the future of statistical programming and drive the next wave of clinical discovery.

Clinical Trial Matching With AI And Large Language Models

Unlock more accurate clinical trial matching by using AI to interpret complex patient notes, reducing the manual screening burden and identifying eligible candidates with higher precision.

The Way Forward: Supply Chain Solutions

Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.

Lyophilization: Protecting And Preserving Biologics

Discover how lyophilization revolutionizes biologic drug manufacturing and ensures potent, stable treatments for complex diseases.

Filtration: The Overlooked Enabler Of Process Intensification

Process intensification depends on more than facility changes. Smarter choices can help improve yield, throughput, and sustainability, turning an often-overlooked step into a meaningful contributor.

SPONSOR

BioFuture 2026 (October 27–28 in New York City) is two days of programming that tackles what biopharma is working through: funding gaps, policy shifts, and AI convergence. More than 500 global attendees address the industry’s hardest questions and build the relationships that move their companies forward. More at https://biofuture.com

Connect With Life Science Leader: